KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
-6.21%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$148M
AUM Growth
+$148M
(-7.7%)
Cap. Flow
+$11.5M
Cap. Flow
% of AUM
7.77%
Top 10 Holdings %
Top 10 Hldgs %
74.02%
Holding
35
New
1
Increased
2
Reduced
–
Closed
–
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.64M |
| 2 |
Altimmune
ALT
|
$3.69M |
| 3 |
CRDL
Cardiol Therapeutics
CRDL
|
$202K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 68.41% |
| 2 | Materials | 20.1% |
| 3 | Industrials | 1.98% |
| 4 | Consumer Staples | 1.26% |
| 5 | Financials | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Royal Gold
RGLD
$11.9B
| $945K | 0.64% |
7,550
| – | – |
|
27
Northrop Grumman
NOC
$83.2B
| $944K | 0.64% |
2,165
| – | – |
|
|
MREO
28
Mereo BioPharma
MREO
$275M
| $938K | 0.63% |
260,470
| – | – |
|
29
CVS Health
CVS
$93B
| $857K | 0.58% |
14,500
| – | – |
|
30
Diageo
DEO
$61.1B
| $851K | 0.57% |
6,750
| – | – |
|
|
NEWP
31
New Pacific Metals
NEWP
$347M
| $728K | 0.49% |
485,000
| – | – |
|
|
SKE
32
Skeena Resources
SKE
$1.97B
| $208K | 0.14% |
38,786
| – | – |
|
|
CRDL
33
Cardiol Therapeutics
CRDL
$91.3M
| $202K | 0.14% |
+100,000
| New | +$202K |
|
|
IRD
34
Opus Genetics, Inc. Common Stock
IRD
$76.7M
| $153K | 0.1% |
100,000
| – | – |
|